Eisai Files Marketing Authorization Application for Lecanemab as Treatment For Early Alzheimer's Disease in South Korea Eisai Jun 08, 2023 12:32 HKT/SGT Read More
エーザイ、抗アミロイドβプロトフィブリル抗体「レカネマブ」について、韓国において早期アルツハイマー病に係る適応で新薬承認を申請 Eisai Jun 08, 2023 09:00 JST Read More
Coya Therapeutics Reports Additional Biomarker and Imaging Data Showing Decrease in Neuroinflammation with COYA 301 in Alzheimer's Disease Coya Therapeutics, Inc. Jun 08, 2023 06:26 HKT/SGT Read More
GeneTex Launches PD-L1 Antibody Comprehensively Validated by MS Validated Antibodies GmbH for Immunohistochemistry GeneTex Jun 06, 2023 20:00 HKT/SGT Read More
Eisai to Present Latest Data on Lemborexant at the 37th Annual Sleep 2023 Meeting Eisai Jun 02, 2023 11:20 HKT/SGT Read More
Asensus Shares First Quarter Results and Future Plans PCG Digital Jun 01, 2023 21:40 HKT/SGT Read More
アバンセ・クリニカルがASCO & BIO 2023に参加 初期段階のオンコロジー試験はより精緻化、より多くの患者を必要とする Avance Clinical May 30, 2023 20:00 JST Read More
TANAKA Precious Metals to Exhibit at "Medtec China 2023" Medical Device Design and Manufacturing Exhibition, to be Held in Suzhou, China TANAKA PRECIOUS METAL GROUP Co., Ltd. May 30, 2023 14:00 HKT/SGT Read More
TANAKA Precious Metals to Exhibit at "Medtec China 2023" Medical Device Design and Manufacturing Exhibition, to be Held in Suzhou, China TANAKA PRECIOUS METAL GROUP Co., Ltd. May 30, 2023 14:00 HKT/SGT Read More
2023 ASCO和BIO上的Avance Clinical:早期肿瘤治疗试验越来越复杂,对患者的需求也越来越大 Avance Clinical May 30, 2023 11:00 HKT/SGT Read More
2023 ASCO和BIO上的Avance Clinical:早期腫瘤治療試驗越來越複雜,對患者的需求也越來越大 Avance Clinical May 30, 2023 11:00 HKT/SGT Read More
ASCO & BIO 2023에서 아방스 임상: 점점 더 정교해지고 더 많은 환자를 요구하는 초기 단계 종양학 시험 Avance Clinical May 30, 2023 11:00 HKT/SGT Read More
Avance Clinical at ASCO & BIO 2023: Early Phase Oncology Trials Increasingly Elaborate and Demand More Patients Avance Clinical May 30, 2023 10:00 HKT/SGT Read More
田中贵金属集团将出展在中国苏州举办的医疗器械制造及设计相关的展会“Medtec China 2023” TANAKA PRECIOUS METAL GROUP Co., Ltd. May 30, 2023 10:00 HKT/SGT Read More
田中贵金属集团将出展在中国苏州举办的医疗器械制造及设计相关的展会“Medtec China 2023” TANAKA PRECIOUS METAL GROUP Co., Ltd. May 30, 2023 10:00 HKT/SGT Read More
LENVIMA (lenvatinib) Plus KEYTRUDA (pembrolizumab) Demonstrates Long-Term, Durable Survival Benefit Versus Sunitinib as First-Line Treatment for Patients With Advanced Renal Cell Carcinoma Eisai May 26, 2023 13:15 HKT/SGT Read More
Codify Self-Care for Advancement of Universal Health Coverage, Says United for Self-Care Coalition at WHA76 United for Self-Care Coalition May 25, 2023 21:10 HKT/SGT Read More
Eisai's Initiatives for Developing New Medicines for Neglected Tropical Diseases and Malaria Eisai May 25, 2023 20:02 HKT/SGT Read More